Kontafarma China Holdings Files Updated Director List with HKEX

Reuters

2025/11/14

Kontafarma China Holdings Files Updated Director List with HKEX

Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2583488505"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583488505\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583488505?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 20:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583488505","market":"us","top_or_hot":-1,"title":"Kontafarma China Holdings Files Updated Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kontafarma China Holdings Files Updated Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kontafarma China Holdings Files Updated Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKontafarma China Holdings Files Updated Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-14 20:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kontafarma China Holdings Files Updated Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDLbjtGpD:1","article_id":"2583488505","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583488505","pubTimestamp":1763123999,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei , Guo Zixiu , and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","01312":"华控康泰"},"translate_title":"Kontafarma China Holdings向香港交易所提交最新董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01312":0.9},"content_text":"Kontafarma China Holdings Files Updated Director List with HKEX\n    \n\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}